PharmaResearch Products’ ‘Rejuran’ acquires Conformity European certificate

Published: 2017-01-25 14:20:42

Updated: 2017-01-25 14:20:42

PharmaResearch Products(CEO Sang-Soo Jung, Won-Jun Ahn), a biotechnology company specializing in regenerative medicine, announced acquisition of the Conformity European Certificate, an European level-3 medical device certificate, for its skin care injection ‘Rejuran.’

‘Rejuran,’ a medical device having ‘PN(polynucleotide)’ extracted from salmon sperm DNA, plays a physical supporter role by bei...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.